Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis.

Baumann, Lukas; Cina, Manuel; Egli-Gany, Dianne; Goutaki, Myrofora; Halbeisen, Florian S; Lohrer, Gian-Reto; Ali, Hammad; Scott, Pippa; Low, Nicola (2018). Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sexually transmitted infections, 94(4), pp. 255-262. BMJ Publishing Group 10.1136/sextrans-2017-053384

[img]
Preview
Text
Baumann SexTransmInfect 2018.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (932kB) | Preview

BACKGROUND is a common cause of non-gonococcal non-chlamydial urethritis and cervicitis. Testing of asymptomatic populations has been proposed, but prevalence in asymptomatic populations is not well established. We aimed to estimate the prevalence ofin the general population, pregnant women, men who have sex with men (MSM), commercial sex workers (CSWs) and clinic-based samples, METHODS: We searched Embase, Medline, IndMED, African Index Medicus and LILACS from 1 January 1991 to 12 July 2016 without language restrictions. We included studies with 500 participants or more. Two reviewers independently screened and selected studies and extracted data. We examined forest plots and conducted random-effects meta-analysis to estimate prevalence, if appropriate. Between-study heterogeneity was examined using the Istatistic and meta-regression. RESULTS Of 3316 screened records, 63 were included. In randomly selected samples from the general population, the summary prevalence was 1.3% (95% CI 1.0% to 1.8%, I41.5%, three studies, 9091 people) in countries with higher levels of development and 3.9% (95% CI 2.2 to 6.7, I89.2%, three studies, 3809 people) in countries with lower levels. Prevalence was similar in women and men (P=0.47). In clinic based samples, prevalence estimates were higher, except in asymptomatic patients (0.8%, 95% CI 0.4 to 1.4, I0.0%, three studies, 2889 people). Summary prevalence estimates were, in the following groups: pregnant women 0.9% (95% CI 0.6% to 1.4%, I0%, four studies, 3472 people), MSM in the community 3.2% (95% CI 2.1 to 5.1, I78.3%, five studies, 3012 people) and female CSWs in the community 15.9% (95% CI 13.5 to 18.9, I79.9%, four studies, 4006 people). DISCUSSION This systematic review can inform testing guidelines for. The low estimated prevalence ofin the general population, pregnant women and asymptomatic attenders at clinics does not support expansion of testing to these groups. REGISTRATION NUMBERS PROSPERO: CRD42015020420.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

Graduate School:

Graduate School for Health Sciences (GHS)

UniBE Contributor:

Egli, Dianne; Goutaki, Myrofora; Halbeisen, Florian Samuel; Scott, Pippa and Low, Nicola

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1368-4973

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Tanya Karrer

Date Deposited:

15 Feb 2018 16:05

Last Modified:

21 Jan 2019 09:10

Publisher DOI:

10.1136/sextrans-2017-053384

PubMed ID:

29440466

Uncontrolled Keywords:

epidemiology (general) meta-analysis systematic rreviews

BORIS DOI:

10.7892/boris.111736

URI:

https://boris.unibe.ch/id/eprint/111736

Actions (login required)

Edit item Edit item
Provide Feedback